BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17296764)

  • 1. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
    Abd El Ghany M; Jansen A; Clare S; Hall L; Pickard D; Kingsley RA; Dougan G
    Infect Immun; 2007 Apr; 75(4):1835-42. PubMed ID: 17296764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
    Hur J; Lee JH
    Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
    Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
    Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
    Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
    Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral administration of attenuated Salmonella Typhimurium ΔznuABC is protective against salmonellosis in piglets.
    Ruggeri J; Pesciaroli M; Gaetarelli B; Scaglione FE; Pregel P; Ammendola S; Battistoni A; Bollo E; Alborali GL; Pasquali P
    Vaccine; 2014 Jul; 32(32):4032-8. PubMed ID: 24907486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms.
    De Ridder L; Maes D; Dewulf J; Butaye P; Pasmans F; Boyen F; Haesebrouck F; Van der Stede Y
    Vet J; 2014 Nov; 202(2):303-8. PubMed ID: 25278382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine.
    Villarreal-Ramos B; Manser J; Collins RA; Dougan G; Chatfield SN; Howard CJ
    Vaccine; 1998 Jan; 16(1):45-54. PubMed ID: 9607008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine.
    Bearson BL; Bearson SMD; Brunelle BW; Bayles DO; Lee IS; Kich JD
    J Med Microbiol; 2017 May; 66(5):651-661. PubMed ID: 28516860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.
    Kodama C; Matsui H
    Infect Immun; 2004 Apr; 72(4):2449-51. PubMed ID: 15039380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter: an efficacious orally-administered mucosal vaccine against salmonellosis in pigs.
    Gradassi M; Pesciaroli M; Martinelli N; Ruggeri J; Petrucci P; Hassan WH; Raffatellu M; Scaglione FE; Ammendola S; Battistoni A; Alborali GL; Pasquali P
    Vaccine; 2013 Aug; 31(36):3695-701. PubMed ID: 23770333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.